Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

ICS-formoterol reliever versus ICS and SABA reliever in asthma: a systematic review and meta-analysis

Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ERJ Open Research 2020; DOI: 10.1183/23120541.00701-2020
Lee Hatter
1Medical Research Institute of New Zealand, Wellington, New Zealand
2National Heart and Lung Institute, Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lee Hatter
  • For correspondence: lee.hatter@mrinz.ac.nz
Pepa Bruce
1Medical Research Institute of New Zealand, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Braithwaite
1Medical Research Institute of New Zealand, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Irene Braithwaite
Mark Holliday
1Medical Research Institute of New Zealand, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Fingleton
1Medical Research Institute of New Zealand, Wellington, New Zealand
3Capital and Coast District Health Board, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James Fingleton
Mark Weatherall
3Capital and Coast District Health Board, Wellington, New Zealand
4University of Otago, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Beasley
1Medical Research Institute of New Zealand, Wellington, New Zealand
3Capital and Coast District Health Board, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Beasley
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/23120541.00701-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received September 27, 2020
  • Accepted October 21, 2020
  • Published online October 29, 2020.

Copyright & Usage 
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Lee Hatter1,2⇑,
  2. Pepa Bruce1,
  3. Irene Braithwaite1,
  4. Mark Holliday1,
  5. James Fingleton1,3,
  6. Mark Weatherall3,4 and
  7. Richard Beasley1,3
  1. 1Medical Research Institute of New Zealand, Wellington, New Zealand
  2. 2National Heart and Lung Institute, Imperial College London, London, United Kingdom
  3. 3Capital and Coast District Health Board, Wellington, New Zealand
  4. 4University of Otago, Wellington, New Zealand
  1. Dr Lee Hatter, Medical Research Institute of New Zealand, Postal address: Private Bag 7902, Newtown, Wellington 6242, New Zealand, Physical address: Level 7, CSB Building, Wellington Regional Hospital, Riddiford Street, Newtown, Wellington 6021, New Zealand. E-mail: lee.hatter{at}mrinz.ac.nz
View Full Text

Article usage

Article usage: October 2020 to December 2020

AbstractFullPdf
Oct 20209247
Nov 20207820769
Dec 20201916493

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ICS-formoterol reliever versus ICS and SABA reliever in asthma: a systematic review and meta-analysis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
ICS-formoterol reliever versus ICS and SABA reliever in asthma: a systematic review and meta-analysis
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ERJ Open Research Jan 2020, 00701-2020; DOI: 10.1183/23120541.00701-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ICS-formoterol reliever versus ICS and SABA reliever in asthma: a systematic review and meta-analysis
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ERJ Open Research Jan 2020, 00701-2020; DOI: 10.1183/23120541.00701-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Respiratory Impedance Measured using Impulse Oscillometry in a Healthy Urban Population
  • Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
  • Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society